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Health-related quality of life assessment using EQ-5D-Y questionnaire in a group of 
Egyptian asthmatic children 
 
INTRODUCTION 
Quality of life is defined as the perception that 
individuals have of their position in life, in the 
context of the culture and system of values in which 
they live and in relation to their objectives, 
expectations, standards, and concerns. Quality of 
life can change according to the environment and 
the experiences, as well as in response to certain 
diseases.1 
Asthma is a common chronic health care 
problem in children and adolescents2 Current 
clinical practice guidelines emphasize that the 
overall goal of asthma management is to achieve 
asthma control.3 The quality of life of children and 
adolescents with asthma deserve special attention, 
because asthma affects not only the individuals with 
the disease, but also their caregivers, thereby 
altering the family's normal life activities.4  
We sought to investigate the health-related 
quality of life (HRQoL) in a group of asthmatic 
children in relation to their asthma severity and 
symptom control. We used the EQ-5D-Y 
questionnaire, which is a generic, youth-specific 
and age-appropriate measure of HRQoL. In 
comparison to other questionnaires, EQ-5D-Y 
questionnaire is relatively short, easy and quick to 
fill, with age-appropriate wording and a short recall 
period and time frame to avoid comprehension and 
memory problems.5 The questionnaire has already 
proved its applicability in various indications and 
populations.6,7 This questionnaire also comprises a 
visual analogue scale (VAS) which is scored from 
zero (worst) to 100 (best) as judged by the patient.  
 
METHODS 
Study design: We conducted an observational, 
cross-sectional, analytical study that was carried out 
at the Pediatric Allergy and Immunology unit, 
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Children’s Hospital, Ain Shams University during 
the period from April 2018 to May 2019.  
Study subjects: The study included three gender 
and age-matched groups of children. The first group 
comprised 100 children, aged 6-12 years, with 
physician-diagnosed persistent asthma with/without 
other allergic disorders. Two control groups were 
recruited; the infection group (n=114) included 
children presenting with acute upper and/or lower 
respiratory tract infections not necessitating hospital 
admission and no present or past history suggestive 
of asthma. The third study group comprised 100 
clinically healthy children. Patients having chronic 
illness other than asthma, or those having 
significant social, medical or environmental 
problems unrelated to asthma were excluded from 
the study. 
Ethical Considerations: Informed consent was 
obtained from the parents before enrollment and 
after explanation of the aim of the study. The study 
protocol gained approval of the local Ethics’ 
Committee of the Pediatric Department, Ain Shams 
University - Cairo, Egypt. 
Study Methods: 
• Detailed clinical evaluation was conducted 
including frequency of asthma symptoms, 
severity, duration, treatment received and 
adherence to treatment, exacerbations, 
hospitalization frequency and the presence of 
other allergic disorders. Physical chest 
examination was performed at enrollment for the 
presence of wheeze and signs of respiratory 
distress. Asthma severity over the past three 
months and asthma control over the past month 
were assessed according to GINA.8 
• Assessment of HRQoL was done by using the 
EQ-5D-Y questionnaire. The EQ-5D-Y 
descriptive system comprises the following five 
dimensions:  
1. Mobility  
2. Looking after myself  
3. Doing usual activities  
4. Having pain or discomfort  
5. Feeling worried, sad or unhappy  
• Each dimension has three levels: no 
problems, some problems and a lot of 
problems. The decision results in a one-digit 
number that expresses the level of severity 
selected for that dimension (1 indicates no 
problems, 2: Some problems and 3: a lot of 
problems). The digits for the five dimensions 
can be combined into a five-digit number that 
describes the patient’s health state and is 
named “health profile”. The EQ-5D-Y 
questionnaire also comprises an additional 
visual analogue scale (VAS). It records the 
patient’s self-rated health on a vertical visual 
analogue scale where the endpoints are 
labelled “The best health you can imagine”- 
scored 100 and “The worst health you can 
imagine”- scored zero.  The VAS can be used 
as a quantitative measure of health outcome 
that reflects the patient’s own judgement.7 
• Subjects were interviewed in the presence of 
their parents/caregivers and the questionnaire 




Data were analyzed using IBM© SPSS© Statistics 
version 23 (IBM© Corp., Armonk, NY). Numerical 
variables were presented as mean and SD and inter-
group differences were compared using one-way 
analysis of variance (ANOVA) with application of 
the Tukey test for post hoc comparison if needed. 
Categorical variables were compared using the 
Pearson chi-squared test or Fisher’s exact test when 
appropriate. Ordinal data were compared using the 
chi-squared test for trend. Associations between 
ordinal and continuous variables were tested using 
the Spearman rank correlation.  Rank bi-serial 
correlation was used to test the association between 
ordinal and nominal variables.  Associations 
between continuous and nominal variables were 
tested using point bi-serial correlation. Probability 
values less than 0.05 were considered significant. 
 
RESULTS 
The age and gender distribution of enrolled children 
are shown in table 1. Among the 100 enrolled 
asthmatic children, 19% had controlled asthma, 
51% had partly controlled asthma and 30% had 
uncontrolled asthma. According to asthma severity, 
58% of patients were categorized as mild to 
moderate and 42% as severe. 
Sixty-four asthmatic children (64%) presented 
for follow up without having asthma exacerbation.  
Sixty-Six patients had associated allergic disorders, 
with allergic rhinitis/rhinosinusitis the most 
frequently reported (n=56; 56%). Other associated 
allergies included urticaria/angioedema (9%), 
allergic rhino conjunctivitis (6%), and eczema 
(4%). Concerning asthma medications, all cases 
were on inhaled corticosteroids (ICS) with 24 % on 
low dose, 70% on medium dose and 6 % on high 
dose ICS. Systemic corticosteroids (SCS) were 
received by only 4% while, 58% were on 
leukotriene receptor antagonists (LTRA). Sixteen 
patients were receiving regular oral vitamin D 
therapy. Ninety-two percent of the cases were 
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adherent to their asthma treatment as reported by 
their parents. 
 
HRQoL in the asthma group  
Dimensions of the EQ-5D-Y questionnaire 
The data showed that 86% of the asthma children 
faced problems with their daily activities (74% of 
them had some problems and 12% had a lot of 
problems). Also, 43 patients with asthma suffered 
from emotional problems in the form of worries, 
sadness or unhappiness in relation to their illness 
(31 patients), while 12 had several of these 
emotional problems (12 patients). Mobility was 
adversely affected in 22% Thirteen percent of the 
cases expressed some pain or discomfort due to 
their disease, while self-care was the least 
commonly affected among asthmatics (6%). These 
results are demonstrated in Figure 1. 
Associations between the EQ-5D-Y questionnaire 
dimensions and asthma patients’ characteristics 
(Tables 2 and 3) 
Mobility problems were positively associated with 
age, disease duration, asthma control and use of 
inhaled long acting beta-2 agonists (LABA) as well 
as moderate positive association with the VAS 
score results. The dimension of doing usual 
activities showed a strong positive association with 
VAS score and moderate positive association with 
the degree of asthma control, but weak positive 
association with the asthma disease duration, and 
intake of SCS and its dose, leukotriene receptor 
antagonist (LTRA) and LABA. The parameter of 
having pain or discomfort showed a strong positive 
association with the VAS scores, but the association 
was weak with age, intake of SCS and its dose and 
asthma control. Feeling worried, sad or unhappy 
showed strong positive association with the VAS 
scores but was moderately associated with age, 
asthma duration and control. Weak positive 
associations were found in relation to asthma 
exacerbations and LABA use, and inverse 
association with adherence to asthma treatment. 
The VAS scores correlated negatively to age, 
frequency of asthma exacerbations, or SCS dose, 
LABA use, asthma duration and level of asthma 
control. 
 
Comparison between the study groups 
EQ-5D-Y dimensions: Parameters of mobility, 
doing usual activities, feeling worried or sad were 
more frequently impacted among the asthmatic 
children in comparison to the other two groups (X2 
= 37.02, 46.38, and 22.89, respectively; p <0.001). 
On the other hand, the parameter of having pain or 
discomfort was most commonly affected among the 
infections’ group in comparison to the other two 
groups. The parameter of looking after myself was 
comparable among the three studied groups (Table 
4).  
VAS score: Asthmatic patients had the lowest VAS 
scores (range: 10-100; mean± SD: 72.2 ± 24.6) in 
comparison to the infection and healthy control 
groups (mean± SD: 84.6 ± 12.2 and 92.8 ± 9.6, 
respectively; f=39.03, p- value = 0.001.  
 
Health profiles  
We outlined 32 different health profiles in this 
study. The three study groups varied significantly in 
their health profiles according to the EQ-5D-Y 
questionnaire (p<0.001). Among asthmatics, there 
were 22 different health profiles, most common 
(39%) of which was 11211 (some problems in 
doing usual activities), followed by 11212 in 17% 
of patients (some problems in the activities and 
emotionally). The most common reported health 
profile in the infection group was 11221 (some 
problems with doing usual activities and having 
pain or discomfort) being expressed in about 51% 
of patients. The health profile 11111 (no problems 
in all five dimensions of the questionnaire) was 
expressed in 27% of healthy control, 13% of 
asthmatics and 3.5% of the infection group. In the 
healthy control group, 11111 (no problems in all 
dimensions of the questionnaire) was the most 




Table 1. Demographic characteristics of the three study groups 
Variable 






F p value* 
Age (years) 8.3 ± 2.1 8.3 ± 1.8 8.2 ± 1.9 2,311 0.815* 
Gender (F/M) 38/62 54/60 48/52 -0.204 0.285# 
Data are mean ± SD or ratio; *One-way analysis of variance (ANOVA); #Fisher’s exact test. 
 







Table 2. Correlation between different EQ-5D-Y dimensions and other variables in asthmatic children 
 





































































































e Coefficient .323** .164 .067 .207* .418** -.348** 






Coefficient .068 -.149 .051 .058 .075 -.062 













Coefficient .205* -.102 .274** .144 .424** -.421** 










s Coefficient .205* .104 .070 .072 .339** -.267** 












s Coefficient -.150 .251* .052 -.080 .059 -.039 












Coefficient .043 -.125 .057 .155 .007 -.001 










l Coefficient .339** .021 .537** .291** .450** -.542** 
P-value .001 .837 <.001 .003 <.001 <.001 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 






Table 3. Correlation between different EQ-5D-Y dimensions and medications, compliance and VAS score in 
asthmatic children 
 











































































































s Coefficient .138 -.052 .207* .225* .047 -.129 












 Coefficient .143 -.052 .207* .231* .048 -.130 










s Coefficient .022 .151 -.069 .055 -.121 .062 





 Coefficient .012 -.126 .206* .088 .194 -.157 





 Coefficient .278** -.021 .264** .030 .373** -.207* 







Coefficient .163 .119 -.036 -.006 .124 -.039 









Coefficient -.199* -.236* -.155 -.105 -.226* .174 









Coefficient -.452** -.323** -.641** -.419** -.860**  
P-value <.001 .001 <.001 <.001 <.001  
*. Correlation is significant at the 0.05 level (2-tailed). 



























n % n % n % 
Mobility 




22 22.0% 0 0.0% 0 0.0% 
A lot of 
problems 
0 0.0% 0 0.0% 0 0.0% 
Looking after 
myself 




6 6.0% 10 8.8% 0 0.0% 
A lot of 
problems 
0 0.0% 0 0.0% 0 0.0% 
Doing usual 
activities 




74 74.0% 95 83.3% 48 48.0% 
A lot of 
problems 
12 12.0% 5 4.4% 0 0.0% 
Having pain or 
discomfort 




13 13.0% 81 71.1% 50 50.0% 
A lot of 
problems 








31 31.0% 7 6.1% 0 0.0% 
A lot of 
problems 
12 12.0% 1 .9% 0 0.0% 






Figure 1. EQ-5D-Y dimensions among the studied asthmatic children. 
 
 








Figure 2. Health profiles according to the EQ-5D-Y questionnaire among the three study groups. 
 
DISCUSSION 
We applied a HRQoL questionnaire on a group of 
asthmatic Egyptian children aiming to investigate 
the real impact of asthma on their quality of life. 
HRQoL was estimated among the asthmatic 
Egyptian children before but none of the studies 
used the EQ-5D-Y questionnaire.10-13 
Healthy children might have their quality of life 
affected owing to several factors including 
multidimensional poverty, crowdedness and 
multiple deprivations related to lack of access to 
services and support mechanisms. It is estimated 
that 28% of Egyptians are living below the national 
monetary poverty line.14 We enrolled children from 
a university hospital that offers medical care for 
economically unprivileged patients. A group of 
children with respiratory tract infections was 
included as a second control group as infection is 
quite prevalent in Egyptian children whether 
asthmatic or not especially in the context of 
malnutrition and poor living conditions.15-17 
The three groups enrolled were quite matched in 
terms of age, gender and socioeconomic status. The 
study revealed that HRQoL is adversely affected in 
the asthmatic group; this was noticeable from their 
health profiles and VAS scores. It involved all 
aspects of children’s lives namely social, mental, 
physical and emotional.  Our findings are consistent 
with many previous studies that investigated and 
discussed the impact of asthma on HRQoL and 
reported significant adverse effects.9,18,19  
The most affected aspect in the asthmatic group 
in our series was the physical function with 
problems in the "doing usual activities" dimension. 
The asthmatic children stated that the main issue 
with activity limitation was in their school 
absenteeism affecting their scholastic achievement, 
in addition to the impact on their playing with peers 
and doing sports. The ability to do their daily 
routine tasks with their families was also impaired. 
This item of the questionnaire showed significant 
positive association with the asthma duration, 
asthma control and VAS score. Furthermore, it 
correlated significantly with the need of add-on 
controllers (LTRA and LABA) and the required 
systemic corticosteroid dose to control symptoms. 
Noteworthy, only 19% of our series had controlled 
asthma while 51% had partly controlled and 30% 
had uncontrolled asthma. 
In agreement with our findings, a study on 
Brazilian children and adolescents with asthma (7-
17 years old) revealed that the activity limitation 
domain was lowest in comparison to other domains 
of the Pediatric Asthma Quality of Life 
Questionnaire (PAQLQ); this was more obvious in 
the children with poorest asthma control and 
greatest asthma severity.20 Similar findings were 
reported as well by Josie et al. in disadvantaged 
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African American youth.21 EQ-5D-Y performed 
better than other generic questionnaires such as 
PedsQL 4.0 which was not sensitive enough to 
distinguish HRQoL between children with different 
levels of asthma severity and control in relation 
physical activity.22 
Mobility also was adversely affected among our 
series as 22% had some problems walking around. 
The main influencing factors on this dimension 
were age, disease duration and asthma control. Poor 
asthma control limits the mobility of asthmatic 
children. In addition, increased disease duration 
might be associated with more structural airway 
changes, further limiting the ability to walk about.23 
Reimberg and colleagues24 noted that asthmatic 
children and adolescents who need regular asthma 
treatment have reduced functional capacity and 
exhibit a sedentary behavior.  
The dimension of feeling worried, sad or 
unhappy was the second most affected parameter of 
HRQoL in our asthmatic group as 31% of children 
reported some problems within this dimension and 
12% suffered a lot of problems. Interviewed 
children attributed that feeling to their fears of 
having exacerbations in an inappropriate place or in 
front of their friends. Bergfors et al 9 studied 94 
Swedish children with asthma, aged 8 to 16 years. 
They used the EQ-5D-Y and the pediatric asthma 
quality of life (PAQLQ) questionnaires and found 
that, emotional and mental aspects were 
significantly affected. In the same context, Shankar 
et al.25 used the Center for Epidemiological Studies 
Depression Scale and found that 28% of 277 urban 
asthmatic adolescents had depressive symptoms 
that were associated with less sleep and impaired 
physical activity. In a relevant study, a generalized 
anxiety disorder and emotional dependency of 
asthmatic children on their care givers were 
observed.26 These observations collectively show 
the importance of psychological support to patients 
and caregivers in the context of asthma 
management. 
We demonstrated that the emotional status of 
asthmatic children is significantly influenced by 
age, asthma duration, presence of exacerbation and 
poor asthma control. As children grow-up, they 
become emotional and stressed due to pubertal 
changes and their disease perception especially 
when they have partial or poor asthma control.27,28 
In a study that comprised 140 Egyptian asthmatic 
children, the authors noted that poor access to 
medications was one of the factors that adversely 
affected the patient PAQLQ scores.11 On the other 
hand, having emotional problems reduces the 
patients’ adherence to treatment leading to reduced 
level of asthma control.29,30   
Having pain or discomfort was affected in only 
13% of our asthma patients. The affection of this 
dimension is expected to occur with acute rather 
than chronic medical illnesses during asthma 
exacerbations and may be linked to poor asthma 
control.31 The dimension named looking after 
myself was the least affected one among the studied 
asthmatic patients with some problems only in 6%. 
Impaired self-care would be expected during acute 
severe asthma exacerbation with marked 
compromise of respiratory functions while our 
series comprised outpatients. This dimension was 
associated with the presence of other concomitant 
allergies which might compromise their ability to 
self-administer excessive medications. 
Asthma control but not asthma severity had 
significant impact on the results of the EQ-5D-Y 
questionnaire as far as several parameters were 
concerned including mobility, doing usual 
activities, having pain or discomfort, and feeling 
worried, sad or unhappy as well as the VAS score. 
Asthma control is probably the most valuable 
determinant of HRQoL whatever the level of 
disease severity is.32-34 
Nevertheless, a proportion of our asthmatic 
children (13%) reported no problems in all the 5 
dimensions. This was previously reported by 
Bergfors et al who used the PAQLQ in addition to 
the EQ-5D-Y and found that 50% of their asthma 
children had a health profile of 11111 denoting no 
problem.9 This observation was considered by some 
investigators to reflect a ceiling effect which means 
that the EQ-5D-Y might not be able to operate 
when the participant’s status is close to full 
health.35,36    
Expectedly, the most frequent reported health 
profile in our asthma patients was 11211 that points 
to having some problems in doing usual activities. 
Among the infection group participants, the health 
profile 11111 represented only 3.5%, while the 
most commonly reported profile was 11221 (having 
pain and discomfort and difficulty in doing usual 
activities). The observation reflects the ability of 
the EQ-5D-Y questionnaire to reflect acute health 
problems including acute infections making them 
feel pain or discomfort. 
In conclusion, our results indicate that bronchial 
asthma has a significant adverse impact on HRQoL 
of children and that EQ-5D-Y questionnaire could 
be a valuable instrument to assess it. The asthmatic 
children had impaired parameters of doing usual 
activities, having pain or discomfort, and feeling 
worried, sad or unhappy, as well as limited 
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mobility. The findings are indeed limited by the 
sample size and cross-sectional study design. The 
consecutive manner of enrollment hindered the 
distribution of the sample according to severity and 
level of control. We recommend the integration of 
asthma related QoL assessment and psychosocial 
screening to the routine pediatric asthma care to 
improve the well being of the children. Prospective 
wider-scale studies are needed to confirm our 
conclusions. Translation and validation of the EQ-
5D-Y questionnaire into the Arabic language is also 
needed to be more feasible and to decrease bias 
during the interpretation of the results. 
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